{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:11:43Z","timestamp":1790183503440,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,3,25]],"date-time":"2017-03-25T00:00:00Z","timestamp":1490400000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100007136","name":"Secretar\u00eda de Estado de Investigaci\u00f3n, Desarrollo e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["IPT-2012-0614-010000"],"award-info":[{"award-number":["IPT-2012-0614-010000"]}],"id":[{"id":"10.13039\/501100007136","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d\u2019Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["2014SGR1115"],"award-info":[{"award-number":["2014SGR1115"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s12035-017-0489-3","type":"journal-article","created":{"date-parts":[[2017,3,25]],"date-time":"2017-03-25T04:01:43Z","timestamp":1490414503000},"page":"2340-2349","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Association of the CX3CR1-V249I Variant with Neurofibrillary Pathology Progression in Late-Onset Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"55","author":[{"given":"Alan","family":"L\u00f3pez-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Gelpi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Maria","family":"Lopategui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5667-4133","authenticated-orcid":false,"given":"Jose M.","family":"Vidal-Taboada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,25]]},"reference":[{"key":"489_CR1","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJMra0909142","volume":"362","author":"HW Querfurth","year":"2010","unstructured":"Querfurth HW, LaFerla FM (2010) Alzheimer\u2019s disease. N Engl J Med 362:329\u2013344. doi:\n10.1056\/NEJMra0909142","journal-title":"N Engl J Med"},{"key":"489_CR2","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","volume":"140","author":"CK Glass","year":"2010","unstructured":"Glass CK, Saijo K, Winner B et al (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140:918\u2013934. doi:\n10.1016\/j.cell.2010.02.016","journal-title":"Cell"},{"key":"489_CR3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/jnen\/62.4.363","volume":"62","author":"L Parkkinen","year":"2003","unstructured":"Parkkinen L, Soininen H, Alafuzoff I (2003) Regional distribution of alpha-synuclein pathology in unimpaired aging and Alzheimer disease. J Neuropathol Exp Neurol 62:363\u2013367","journal-title":"J Neuropathol Exp Neurol"},{"key":"489_CR4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-3-7091-6846-2_7","volume":"51","author":"LA Hansen","year":"1997","unstructured":"Hansen LA (1997) The Lewy body variant of Alzheimer disease. J Neural Transm Suppl 51:83\u201393","journal-title":"J Neural Transm Suppl"},{"key":"489_CR5","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s11064-012-0708-2","volume":"37","author":"JS Rao","year":"2012","unstructured":"Rao JS, Kellom M, Kim H-W, Rapoport SI (2012) Neuroinflammation and synaptic loss. Neurochem Res 37:903\u2013910. doi:\n10.1007\/s11064-012-0708-2","journal-title":"Neurochem Res"},{"key":"489_CR6","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1093\/brain\/awv288","volume":"138","author":"Z Fan","year":"2015","unstructured":"Fan Z, Okello AA, Brooks DJ, Edison P (2015) Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer\u2019s disease. Brain J Neurol 138:3685\u20133698. doi:\n10.1093\/brain\/awv288","journal-title":"Brain J Neurol"},{"key":"489_CR7","doi-asserted-by":"publisher","first-page":"8090918","DOI":"10.1155\/2016\/8090918","volume":"2016","author":"P Chen","year":"2016","unstructured":"Chen P, Zhao W, Guo Y et al (2016) CX3CL1\/CX3CR1 in Alzheimer\u2019s disease: A target for Neuroprotection. Biomed Res Int 2016:8090918. doi:\n10.1155\/2016\/8090918","journal-title":"Biomed Res Int"},{"key":"489_CR8","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.neuron.2006.01.022","volume":"49","author":"AR Simard","year":"2006","unstructured":"Simard AR, Soulet D, Gowing G et al (2006) Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer\u2019s disease. Neuron 49:489\u2013502. doi:\n10.1016\/j.neuron.2006.01.022","journal-title":"Neuron"},{"key":"489_CR9","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00281-013-0382-8","volume":"35","author":"VH Perry","year":"2013","unstructured":"Perry VH, Teeling J (2013) Microglia and macrophages of the central nervous system: The contribution of microglia priming and systemic inflammation to chronic neurodegeneration. Semin Immunopathol 35:601\u2013612. doi:\n10.1007\/s00281-013-0382-8","journal-title":"Semin Immunopathol"},{"key":"489_CR10","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J et al (2015) Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol 14:388\u2013405. doi:\n10.1016\/S1474-4422(15)70016-5","journal-title":"Lancet Neurol"},{"key":"489_CR11","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.tins.2015.08.011","volume":"38","author":"M Meyer-Luehmann","year":"2015","unstructured":"Meyer-Luehmann M, Prinz M (2015) Myeloid cells in Alzheimer\u2019s disease: Culprits, victims or innocent bystanders? Trends Neurosci 38:659\u2013668. doi:\n10.1016\/j.tins.2015.08.011","journal-title":"Trends Neurosci"},{"key":"489_CR12","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/ng.801","volume":"43","author":"AC Naj","year":"2011","unstructured":"Naj AC, Jun G, Beecham GW et al (2011) Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer\u2019s disease. Nat Genet 43:436\u2013441. doi:\n10.1038\/ng.801","journal-title":"Nat Genet"},{"key":"489_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/B978-0-12-800149-3.00005-6","volume":"87","author":"V Chouraki","year":"2014","unstructured":"Chouraki V, Seshadri S (2014) Genetics of Alzheimer\u2019s disease. Adv Genet 87:245\u2013294. doi:\n10.1016\/B978-0-12-800149-3.00005-6","journal-title":"Adv Genet"},{"key":"489_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","volume":"77","author":"CM Karch","year":"2015","unstructured":"Karch CM, Goate AM (2015) Alzheimer\u2019s disease risk genes and mechanisms of disease pathogenesis. Biol Psychiatry 77:43\u201351. doi:\n10.1016\/j.biopsych.2014.05.006","journal-title":"Biol Psychiatry"},{"key":"489_CR15","doi-asserted-by":"publisher","first-page":"6501","DOI":"10.1007\/s12035-015-9546-y","volume":"53","author":"Z Wang","year":"2016","unstructured":"Wang Z, Lei H, Zheng M et al (2016) Meta-analysis of the association between Alzheimer disease and variants in GAB2, PICALM, and SORL1. Mol Neurobiol 53:6501\u20136510. doi:\n10.1007\/s12035-015-9546-y","journal-title":"Mol Neurobiol"},{"key":"489_CR16","doi-asserted-by":"publisher","unstructured":"Rai V (2016) Methylenetetrahydrofolate Reductase (MTHFR) C677T polymorphism and Alzheimer disease risk: A meta-analysis. Mol Neurobiol:1\u201314. doi:\n10.1007\/s12035-016-9722-8","DOI":"10.1007\/s12035-016-9722-8"},{"key":"489_CR17","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1365-2990.2011.01181.x","volume":"37","author":"K Morgan","year":"2011","unstructured":"Morgan K (2011) The three new pathways leading to Alzheimer\u2019s disease. Neuropathol Appl Neurobiol 37:353\u2013357. doi:\n10.1111\/j.1365-2990.2011.01181.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"489_CR18","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00401-012-0996-2","volume":"124","author":"GD Schellenberg","year":"2012","unstructured":"Schellenberg GD, Montine TJ (2012) The genetics and neuropathology of Alzheimer\u2019s disease. Acta Neuropathol (Berl) 124:305\u2013323. doi:\n10.1007\/s00401-012-0996-2","journal-title":"Acta Neuropathol (Berl)"},{"key":"489_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-015-9683-3","author":"X Dong","year":"2016","unstructured":"Dong X, Zhang L, Meng Q, Gao Q (2016) Association between interleukin-1A, interleukin-1B, and bridging integrator 1 polymorphisms and Alzheimer\u2019s disease: A standard and cumulative meta-analysis. Mol Neurobiol. doi:\n10.1007\/s12035-015-9683-3","journal-title":"Mol Neurobiol"},{"key":"489_CR20","doi-asserted-by":"publisher","first-page":"4814","DOI":"10.1093\/hmg\/ddu196","volume":"23","author":"C Linnertz","year":"2014","unstructured":"Linnertz C, Lutz MW, Ervin JF et al (2014) The genetic contributions of SNCA and LRRK2 genes to Lewy body pathology in Alzheimer\u2019s disease. Hum Mol Genet 23:4814\u20134821. doi:\n10.1093\/hmg\/ddu196","journal-title":"Hum Mol Genet"},{"key":"489_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J et al (2013) TREM2 variants in Alzheimer\u2019s disease. N Engl J Med 368:117\u2013127. doi:\n10.1056\/NEJMoa1211851","journal-title":"N Engl J Med"},{"key":"489_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-015-2274-2","author":"Y Lu","year":"2015","unstructured":"Lu Y, Liu W, Wang X (2015) TREM2 variants and risk of Alzheimer\u2019s disease: A meta-analysis. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. doi:\n10.1007\/s10072-015-2274-2","journal-title":"Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol"},{"key":"489_CR23","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nn.3435","volume":"16","author":"EM Bradshaw","year":"2013","unstructured":"Bradshaw EM, Chibnik LB, Keenan BT et al (2013) CD33 Alzheimer\u2019s disease locus: Altered monocyte function and amyloid biology. Nat Neurosci 16:848\u2013850. doi:\n10.1038\/nn.3435","journal-title":"Nat Neurosci"},{"key":"489_CR24","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","volume":"78","author":"A Griciuc","year":"2013","unstructured":"Griciuc A, Serrano-Pozo A, Parrado AR et al (2013) Alzheimer\u2019s disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron 78:631\u2013643. doi:\n10.1016\/j.neuron.2013.04.014","journal-title":"Neuron"},{"key":"489_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3389\/fncel.2013.00026","volume":"7","author":"Y Wolf","year":"2013","unstructured":"Wolf Y, Yona S, Kim K-W, Jung S (2013) Microglia, seen from the CX3CR1 angle. Front Cell Neurosci 7:26. doi:\n10.3389\/fncel.2013.00026","journal-title":"Front Cell Neurosci"},{"key":"489_CR26","doi-asserted-by":"publisher","first-page":"130181","DOI":"10.1098\/rsob.130181","volume":"3","author":"GK Sheridan","year":"2013","unstructured":"Sheridan GK, Murphy KJ (2013) Neuron-glia crosstalk in health and disease: Fractalkine and CX3CR1 take centre stage. Open Biol 3:130181. doi:\n10.1098\/rsob.130181","journal-title":"Open Biol"},{"key":"489_CR27","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nn1715","volume":"9","author":"AE Cardona","year":"2006","unstructured":"Cardona AE, Pioro EP, Sasse ME et al (2006) Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci 9:917\u2013924. doi:\n10.1038\/nn1715","journal-title":"Nat Neurosci"},{"key":"489_CR28","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.2353\/ajpath.2010.100265","volume":"177","author":"S Lee","year":"2010","unstructured":"Lee S, Varvel NH, Konerth ME et al (2010) CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer\u2019s disease mouse models. Am J Pathol 177:2549\u20132562. doi:\n10.2353\/ajpath.2010.100265","journal-title":"Am J Pathol"},{"key":"489_CR29","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1093\/brain\/awt323","volume":"137","author":"I Lastres-Becker","year":"2014","unstructured":"Lastres-Becker I, Innamorato NG, Jaworski T et al (2014) Fractalkine activates NRF2\/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis. Brain J Neurol 137:78\u201391. doi:\n10.1093\/brain\/awt323","journal-title":"Brain J Neurol"},{"key":"489_CR30","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1172\/JCI16790","volume":"111","author":"DH McDermott","year":"2003","unstructured":"McDermott DH, Fong AM, Yang Q et al (2003) Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans. J Clin Invest 111:1241\u20131250. doi:\n10.1172\/JCI16790","journal-title":"J Clin Invest"},{"key":"489_CR31","doi-asserted-by":"publisher","first-page":"19649","DOI":"10.1074\/jbc.M313457200","volume":"279","author":"M Daoudi","year":"2004","unstructured":"Daoudi M, Lavergne E, Garin A et al (2004) Enhanced adhesive capacities of the naturally occurring Ile249\u2013Met280 variant of the chemokine receptor CX3CR1. J Biol Chem 279:19649\u201319657. doi:\n10.1074\/jbc.M313457200","journal-title":"J Biol Chem"},{"key":"489_CR32","doi-asserted-by":"publisher","first-page":"e96528","DOI":"10.1371\/journal.pone.0096528","volume":"9","author":"A Lopez-Lopez","year":"2014","unstructured":"Lopez-Lopez A, Gamez J, Syriani E et al (2014) CX3CR1 is a modifying gene of survival and progression in amyotrophic lateral sclerosis. PLoS One 9:e96528. doi:\n10.1371\/journal.pone.0096528","journal-title":"PLoS One"},{"key":"489_CR33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3109\/00207454.2012.723079","volume":"123","author":"B Arli","year":"2013","unstructured":"Arli B, Irkec C, Menevse S et al (2013) Fractalkine gene receptor polymorphism in patients with multiple sclerosis. Int J Neurosci 123:31\u201337. doi:\n10.3109\/00207454.2012.723079","journal-title":"Int J Neurosci"},{"key":"489_CR34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1572-0241.2005.00361.x","volume":"101","author":"S Brand","year":"2006","unstructured":"Brand S, Hofbauer K, Dambacher J et al (2006) Increased expression of the chemokine Fractalkine in Crohn\u2019s disease and association of the Fractalkine receptor T280M polymorphism with a Fibrostenosing disease phenotype. Am J Gastroenterol 101:99\u2013106","journal-title":"Am J Gastroenterol"},{"key":"489_CR35","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1126\/science.287.5461.2274","volume":"287","author":"S Faure","year":"2000","unstructured":"Faure S, Meyer L, Costagliola D et al (2000) Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1. Science 287:2274\u20132277. doi:\n10.1126\/science.287.5461.2274","journal-title":"Science"},{"key":"489_CR36","doi-asserted-by":"publisher","first-page":"5590","DOI":"10.1167\/iovs.15-16830","volume":"56","author":"R Zhang","year":"2015","unstructured":"Zhang R, Wang L-Y, Wang Y-F et al (2015) Associations between the T280M and V249I SNPs in CX3CR1 and the risk of age-related macular degeneration. Invest Ophthalmol Vis Sci 56:5590\u20135598. doi:\n10.1167\/iovs.15-16830","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"489_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG et al (2012) National Institute on Aging-Alzheimer\u2019s association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: A practical approach. Acta Neuropathol (Berl) 123:1\u201311. doi:\n10.1007\/s00401-011-0910-3","journal-title":"Acta Neuropathol (Berl)"},{"key":"489_CR38","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T et al (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol (Berl) 112:389\u2013404. doi:\n10.1007\/s00401-006-0127-z","journal-title":"Acta Neuropathol (Berl)"},{"key":"489_CR39","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/bioinformatics\/btm025","volume":"23","author":"JR Gonz\u00e1lez","year":"2007","unstructured":"Gonz\u00e1lez JR, Armengol L, Sol\u00e9 X et al (2007) SNPassoc: An R package to perform whole genome association studies. Bioinforma Oxf Engl 23:644\u2013645. doi:\n10.1093\/bioinformatics\/btm025","journal-title":"Bioinforma Oxf Engl"},{"key":"489_CR40","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1007\/s00415-015-7843-z","volume":"262","author":"JM Vidal-Taboada","year":"2015","unstructured":"Vidal-Taboada JM, Lopez-Lopez A, Salvado M et al (2015) UNC13A confers risk for sporadic ALS and influences survival in a Spanish cohort. J Neurol 262:2285\u20132292. doi:\n10.1007\/s00415-015-7843-z","journal-title":"J Neurol"},{"key":"489_CR41","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1093\/brain\/awv081","volume":"138","author":"N Maphis","year":"2015","unstructured":"Maphis N, Xu G, Kokiko-Cochran ON et al (2015) Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain. Brain J Neurol 138:1738\u20131755. doi:\n10.1093\/brain\/awv081","journal-title":"Brain J Neurol"},{"key":"489_CR42","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1182\/blood.V97.7.1925","volume":"97","author":"D Moatti","year":"2001","unstructured":"Moatti D, Faure S, Fumeron F et al (2001) Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood 97:1925\u20131928. doi:\n10.1182\/blood.V97.7.1925","journal-title":"Blood"},{"key":"489_CR43","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1097\/NEN.0000000000000018","volume":"72","author":"M Colom-Cadena","year":"2013","unstructured":"Colom-Cadena M, Gelpi E, Charif S et al (2013) Confluence of \u03b1-synuclein, tau, and \u03b2-amyloid pathologies in dementia with Lewy bodies. J Neuropathol Exp Neurol 72:1203\u20131212. doi:\n10.1097\/NEN.0000000000000018","journal-title":"J Neuropathol Exp Neurol"},{"key":"489_CR44","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/brain\/awr031","volume":"134","author":"Y Compta","year":"2011","unstructured":"Compta Y, Parkkinen L, O\u2019Sullivan SS et al (2011) Lewy- and Alzheimer-type pathologies in Parkinson\u2019s disease dementia: Which is more important? Brain J Neurol 134:1493\u20131505. doi:\n10.1093\/brain\/awr031","journal-title":"Brain J Neurol"},{"key":"489_CR45","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12308","author":"M Sierra","year":"2016","unstructured":"Sierra M, Gelpi E, Mart\u00ed MJ, Compta Y (2016) Lewy- and alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum. Neuropathol Appl Neurobiol. doi:\n10.1111\/nan.12308","journal-title":"Neuropathol Appl Neurobiol"},{"key":"489_CR46","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1089\/gtmb.2011.0256","volume":"16","author":"N Singh","year":"2012","unstructured":"Singh N, Rai H, Sinha N et al (2012) Association of V249I and T280M polymorphisms in the chemokine receptor CX3CR1 gene with early onset of coronary artery disease among north Indians. Genet Test Mol Biomark 16:756\u2013760. doi:\n10.1089\/gtmb.2011.0256","journal-title":"Genet Test Mol Biomark"},{"key":"489_CR47","doi-asserted-by":"publisher","DOI":"10.1160\/TH04-11-0735","author":"A Niessner","year":"2005","unstructured":"Niessner A, Marculescu R, Haschemi A et al (2005) Opposite effects of CX3CR1 receptor polymorphisms V2491 and T280M on the development of acute coronary syndrome. A possible implication of fractalkine in inflammatory activation Thromb Haemost doi. doi:\n10.1160\/TH04-11-0735","journal-title":"A possible implication of fractalkine in inflammatory activation Thromb Haemost doi"},{"key":"489_CR48","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1146\/annurev.iy.12.040194.003113","volume":"12","author":"PM Murphy","year":"1994","unstructured":"Murphy PM (1994) The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol 12:593\u2013633. doi:\n10.1146\/annurev.iy.12.040194.003113","journal-title":"Annu Rev Immunol"},{"key":"489_CR49","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ et al (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science 261:921\u2013923","journal-title":"Science"},{"key":"489_CR50","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1212\/WNL.48.1.139","volume":"48","author":"D Blacker","year":"1997","unstructured":"Blacker D, Haines JL, Rodes L et al (1997) ApoE-4 and age at onset of Alzheimer\u2019s disease: The NIMH genetics initiative. Neurology 48:139\u2013147","journal-title":"Neurology"},{"key":"489_CR51","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2377-8-9","volume":"8","author":"SB Sando","year":"2008","unstructured":"Sando SB, Melquist S, Cannon A et al (2008) APOE \u03b54 lowers age at onset and is a high risk factor for Alzheimer\u2019s disease; a case control study from central Norway. BMC Neurol 8:9. doi:\n10.1186\/1471-2377-8-9","journal-title":"BMC Neurol"},{"key":"489_CR52","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1001\/archneur.64.4.501","volume":"64","author":"JH Lee","year":"2007","unstructured":"Lee JH, Cheng R, Schupf N et al (2007) The association between genetic variants in SORL1 and Alzheimer disease in an urban, multiethnic, community-based cohort. Arch Neurol 64:501\u2013506. doi:\n10.1001\/archneur.64.4.501","journal-title":"Arch Neurol"},{"key":"489_CR53","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/mp.2014.81","volume":"20","author":"V Leduc","year":"2015","unstructured":"Leduc V, De Beaumont L, Th\u00e9roux L et al (2015) HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer\u2019s disease in a three cohorts study. Mol Psychiatry 20:867\u2013873. doi:\n10.1038\/mp.2014.81","journal-title":"Mol Psychiatry"},{"key":"489_CR54","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1001\/jamaneurol.2014.1491","volume":"71","author":"AC Naj","year":"2014","unstructured":"Naj AC, Jun G, Reitz C et al (2014) Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: A genome-wide association study. JAMA Neurol 71:1394\u20131404. doi:\n10.1001\/jamaneurol.2014.1491","journal-title":"JAMA Neurol"},{"key":"489_CR55","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1086\/339815","volume":"70","author":"Y-J Li","year":"2002","unstructured":"Li Y-J, Scott WK, Hedges DJ et al (2002) Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet 70:985\u2013993. doi:\n10.1086\/339815","journal-title":"Am J Hum Genet"},{"key":"489_CR56","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10048-007-0103-3","volume":"9","author":"JH Lee","year":"2008","unstructured":"Lee JH, Barral S, Cheng R et al (2008) Age-at-onset linkage analysis in Caribbean Hispanics with familial late-onset Alzheimer\u2019s disease. Neurogenetics 9:51\u201360. doi:\n10.1007\/s10048-007-0103-3","journal-title":"Neurogenetics"},{"key":"489_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.32133","author":"W Zhao","year":"2013","unstructured":"Zhao W, Marchani EE, Cheung CYK et al (2013) Genome scan in familial late-onset Alzheimer\u2019s disease: A locus on chromosome 6 contributes to age at onset. Am J Med Genet Part B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet. doi:\n10.1002\/ajmg.b.32133","journal-title":"Am J Med Genet Part B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet"},{"key":"489_CR58","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1056\/NEJMra0905980","volume":"363","author":"TA Manolio","year":"2010","unstructured":"Manolio TA (2010) Genomewide association studies and assessment of the risk of disease. N Engl J Med 363:166\u2013176. doi:\n10.1056\/NEJMra0905980","journal-title":"N Engl J Med"},{"key":"489_CR59","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1212\/WNL.0b013e31821a44dd","volume":"76","author":"M Balasa","year":"2011","unstructured":"Balasa M, Gelpi E, Antonell A et al (2011) Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease. Neurology 76:1720\u20131725. doi:\n10.1212\/WNL.0b013e31821a44dd","journal-title":"Neurology"},{"key":"489_CR60","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000321984","volume":"31","author":"S Crean","year":"2011","unstructured":"Crean S, Ward A, Mercaldi CJ et al (2011) Apolipoprotein E \u03b54 prevalence in Alzheimer\u2019s disease patients varies across global populations: A systematic literature review and meta-analysis. Dement Geriatr Cogn Disord 31:20\u201330. doi:\n10.1159\/000321984","journal-title":"Dement Geriatr Cogn Disord"},{"key":"489_CR61","doi-asserted-by":"publisher","first-page":"5838","DOI":"10.1093\/hmg\/ddu277","volume":"23","author":"SC Jin","year":"2014","unstructured":"Jin SC, Benitez BA, Karch CM et al (2014) Coding variants in TREM2 increase risk for Alzheimer\u2019s disease. Hum Mol Genet 23:5838\u20135846. doi:\n10.1093\/hmg\/ddu277","journal-title":"Hum Mol Genet"},{"key":"489_CR62","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s00702-015-1369-5","volume":"122","author":"S Strobel","year":"1996","unstructured":"Strobel S, Gr\u00fcnblatt E, Riederer P et al (1996) (2015) changes in the expression of genes related to neuroinflammation over the course of sporadic Alzheimer\u2019s disease progression: CX3CL1, TREM2, and PPAR\u03b3. J Neural Transm Vienna Austria 122:1069\u20131076. doi:\n10.1007\/s00702-015-1369-5","journal-title":"J Neural Transm Vienna Austria"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-017-0489-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-017-0489-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-017-0489-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T23:12:24Z","timestamp":1520291544000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-017-0489-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,25]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["489"],"URL":"https:\/\/doi.org\/10.1007\/s12035-017-0489-3","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,25]]}}}